Sir, Leptin (Greek "leptos" = "thin") is a hormone that helps to regulate metabolism by inhibiting food intake and promoting energy expenditure. In addition to being a key factor in regulating body weight, leptin plays an important role in the regulation of immune system and various other physiological responses. [1] Congenital leptin deficiency, caused by LEP gene mutation and inherited as an autosomal recessive disorder, presents with severe obesity early in life, following a normal birth weight. Affected individuals suffer from hypogonadotropic-hypogonadism, which if untreated leads to delayed puberty and infertility. This form of leptin deficiency is extremely rare with less than 30 patients reported in the literature so far. [2] Leptin deficiency is also suspected to be involved in the pathophysiology of ANCA-associated vasculitis (AAV). Kümpers et al. found that leptin levels are negatively correlated with the disease activity. [3] Further studies are needed to gauge the role of leptin as a potential therapeutic target in the treatment of autoimmune disorders.
A 10-year-old girl, a product of second degree consanguineous marriage, first in birth order, presented with multiple painful, red, raised lesions on the trunk and extremities since 5 days. Examination revealed palpable purpura and ulcerations of variable sizes and shapes over the legs, arms, forearms, dorsa of hands and feet, chest, and abdomen [ Figures 1 and 2 ]. There was predominant extensor distribution with koebnerization appreciated at places. Mucosae were not involved. General physical examination revealed moon facies [ Figure 3 ], morbid obesity with a weight of 90 kg, height 137 cm, and a BMI of 47.95. She had difficulty in walking due to excessive weight. Acanthosis nigricans was also noted in the axilla and neck [ Figure 4 ]. Rest of the systemic examination was within normal limits. Investigations revealed neutrophilic leukocytosis (white blood cell count -19,950/cumm; N = 80.5, L = 17, M = 5.9, E = 01). Liver and renal parameters, routine and 24 h urinary examination were unremarkable. Rheumatoid factor, hepatitis B surface antigen, anti-HCV antibodies, HIV ELISA, antinuclear antibody, lupus anticoagulant, and cryoglobulins were also negative. Fasting plasma CORRESPONDENCE glucose and insulin levels were normal. Triglycerides were marginally raised. cANCA was positive, and skin According to her parents, the patient had uneventful antenatal and perinatal period and was apparently normal till the age of 6 months when they suspected excessive eating and weight gain by the child. The consultation was sought for the same, and the child was evaluated for leptin deficiency in view of the early onset obesity. Her anthropometric measurements at that time were: weight 10.75 kg (>95 th percentile), height 64.4 cm (between 25 th and 50 th percentile), and BMI 25.84 kg/m 2 . Baseline investigations, echocardiography, serum cortisol level, and thyroid function test did not reveal any abnormality. Serum leptin levels were inappropriately low 0.8 ng/ml (1.7-10.9 ng/ml). The patient was diagnosed as a case of leptin deficiency but was subsequently lost to follow-up till date when the patient reported to us with the purpuric rash. During the intervening period, the patient had normal developmental milestones with no mental retardation or language deficit.
There was also history of excessive weight gain in her younger 9-month-old male sibling [ Figure 6 ]. He likewise was of normal weight at birth but was presently obese. His weight was 9 kg (>90 th centile), length was 64 cm (10 th centile), and BMI was 21.97 kg/m 2 .On evaluation, he too was diagnosed as having leptin deficiency (Serum leptin levels: 1.1 ng/ml). Due to unavailability at our center, genetic analysis could not be performed in either of the two cases.
The index case was treated with tapering doses of steroids and showed remarkable improvement of skin lesions. Endocrinology consultation was sought. She was advised leptin replacement therapy which could not be administered, as the patient could not afford the same.
Congenital leptin deficiency is one of the rare causes of early-onset obesity. It was first described in two cousins from an inbred Pakistani kindred by Montague et al. [4] Subsequent cases were reported by Farooqi et al., Gibson et al., Strobel et al. and Wabitsch et al. [5] [6] [7] [8] A homozygous frameshift or missense mutation in the LEP gene (7q31.3) results in the characteristic phenotype of severe hyperphagia and extreme obesity early in infancy. Administration of recombinant human leptin [recombinant methionyl human leptin (r-metHuLeptin)] has resulted in sustained positive results in this non-syndromic disorder of excessive weight gain. Active ANCA-associated vasculitis is associated with functionally defective regulatory T cells and consequently decreased levels of leptin. Kümpers et al. suggested that low levels of leptin may enhance the inflammatory process in disorders that involve innate immunity. Invasion and destruction of activated endothelium by primed neutrophils is a salient feature of vasculitis. Notably, leptin may partake in this process because microvascular endothelial cells and neutrophils both express the leptin receptor. It is thus conceivable that leptin attenuates the neutrophil chemotaxis in vasculitis. Further effects of leptin on microvascular endothelial cells include increased proliferation and inhibition of apoptosis. However, on the contrary, Yilmaz et al. have shown that Leptin level was higher in Takayasu arteritis patients than in healthy controls albeit the difference was not statistically significant. [9] Similarly, studies performed in other forms of systemic vasculitis (Henoch-Schönlein purpura and Behcet's disease) have shown increased levels of leptin during active disease periods. [10, 11] Whether leptin has a role in vasculitis or its altered levels in this disorder is a mere coincidental finding needs to be probed. Larger studies are required to consolidate this finding. Our case emphasizes the need for early detection of congenital leptin deficiency, which if misdiagnosed runs the risk of severe obesity-associated complications (especially type II diabetes).
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